<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="oil1000/PMC6539774/results/search/disease/results.xml">
  <result pre="Creative Commons Attribution (CC BY) license ( http://creativecommons.org/licenses/by/4.0/). Abstract Childhood" exact="obesity" post="represents an important public health issue worldwide and is"/>
  <result pre="health through epigenetic changes, playing a potential role in determining" exact="obesity" post="and obesity-related complications. Understanding how nutritional epigenetic mechanisms contribute"/>
  <result pre="how nutritional epigenetic mechanisms contribute to the &quot;transgenerational risk&quot; for" exact="obesity" post="and metabolic dysfunction is crucial in order to develop"/>
  <result pre="the possible interaction between n-3 LCPUFAs and epigenetic pathways in" exact="metabolic syndrome." post="Literature from MEDLINE ® and the Cochrane database between"/>
  <result pre="2005 and December 2018 has been scanned. DHA LCPUFAs pediatric" exact="obesity" post="metabolic syndrome epigenetics nutritional programming 1. Introduction Childhood obesity"/>
  <result pre="and December 2018 has been scanned. DHA LCPUFAs pediatric obesity" exact="metabolic syndrome" post="epigenetics nutritional programming 1. Introduction Childhood obesity is an"/>
  <result pre="pediatric obesity metabolic syndrome epigenetics nutritional programming 1. Introduction Childhood" exact="obesity" post="is an important public health problem all over the"/>
  <result pre="public health problem all over the world. The prevalence of" exact="obesity" post="has increased in school-aged children from the 1980s (from"/>
  <result pre="in its third edition in 2012, revealed that overweight and" exact="obesity" post="rates among primary school-children ranged from 18–52% in boys"/>
  <result pre="13–43% in girls. The data showed a higher percentage of" exact="obesity" post="in Southern European countries, although these are traditionally recognized"/>
  <result pre="obese. Between the years 2008 and 2016, the prevalence of" exact="obesity" post="decreased from 12% to 9.3% (with a percentage reduction"/>
  <result pre="children [ 7]. A chronic, low-grade inflammatory state driven by" exact="obesity" post="leads to metabolic alterations responsible for vascular dysfunction, thrombotic"/>
  <result pre="cardiovascular outcome and all-cause mortality are higher in patients with" exact="metabolic syndrome" post="[ 9]. Though genetic, socio-economic, and environmental factors have"/>
  <result pre="well-known risk factor for cardio-metabolic complications and the incidence of" exact="metabolic syndrome" post="[ 9]. Hence, strategies for prevention and treatment of"/>
  <result pre="[ 9]. Hence, strategies for prevention and treatment of pediatric" exact="obesity" post="are needed to reduce short- and long-term morbidities and"/>
  <result pre="epigenetic modifications could play a role in the development of" exact="obesity" post="and metabolic syndrome. Epigenetics include all heritable changes in"/>
  <result pre="could play a role in the development of obesity and" exact="metabolic syndrome." post="Epigenetics include all heritable changes in the regulation of"/>
  <result pre="development, determining metabolic pathways that, if persistent, could lead to" exact="obesity" post="in the newborn. This &quot;gestational programming&quot;, triggered by suboptimal"/>
  <result pre="play as possible factors in modulating gene expression and promoting" exact="metabolic syndrome" post="features [ 11]. Due to the potential reversible nature"/>
  <result pre="of epigenetic changes, disclosing their contribution to transgenerational transmission of" exact="obesity" post="and metabolic dysfunction is crucial to formulate detection and"/>
  <result pre="crucial to formulate detection and prevention strategies to avoid &quot;programmed&quot;" exact="metabolic syndrome." post="LCPUFAs are well known for their health benefits, especially"/>
  <result pre="improve some obesity-associated complications such as insulin resistance, hypertension, and" exact="dyslipidemia" post="by decreasing plasma triglycerides. Recent research is focusing on"/>
  <result pre="epigenetic mechanisms of n-3 LCPUFAs and their potential role in" exact="metabolic syndrome" post="components. 3. Biochemistry and Biologic Function of LCPUFA LCPUFAs"/>
  <result pre="Metabolic Syndrome in Children Children who are overweight and pediatric" exact="obesity" post="represent an emerging public health priority as rates have"/>
  <result pre="included due to insufficient data available). In all groups, abdominal" exact="obesity" post="is the necessary condition to make the diagnosis. The"/>
  <result pre="the diagnosis. The IDF consensus also recommends not to diagnose" exact="metabolic syndrome" post="in children younger than 10 years; while it is"/>
  <result pre="For the group of children aged 10 years or older," exact="metabolic syndrome" post="can be diagnosed with abdominal obesity and associated with"/>
  <result pre="years or older, metabolic syndrome can be diagnosed with abdominal" exact="obesity" post="and associated with two or more other clinical features,"/>
  <result pre="features that increase a patients’ cardiovascular risk. Several definitions for" exact="metabolic syndrome" post="in adults have been proposed, leading to some difficulty"/>
  <result pre="currently accepted that supplementation with n-3 LCPUFAs might improve some" exact="metabolic syndrome" post="features such as insulin resistance, hypertension, and dyslipidemia, mainly"/>
  <result pre="g for three months has a beneficial effect also in" exact="metabolic syndrome" post="patients, determining a reduction in triglycerides from 7–25% ["/>
  <result pre="oil also plays a role in reducing intracellular lipolysis by" exact="suppression" post="of inflammation in adipose tissue [ 30]. Fish oil"/>
  <result pre="their modulation could act as a therapeutic strategy also for" exact="metabolic syndrome." post="5.2. Trials in Children Despite the extensive literature available"/>
  <result pre="performed to study if DHA supplementation has an effect on" exact="metabolic syndrome" post="determinants in children. There is emerging evidence from epidemiological"/>
  <result pre="suggesting that LCPUFA supplementation could not influence the prevalence of" exact="metabolic syndrome" post="[ 50]. A study evaluated the effect of LCPUFA"/>
  <result pre="that PPAR-α is responsible for lipid homeostasis and thereby prevents" exact="dyslipidemia" post="[ 52]. PPAR-γ is involved in adipocyte differentiation and"/>
  <result pre="the potential benefits of LCPUFAs on preventing newborn risk of" exact="obesity" post="and its metabolic complications. It is unclear how LCPUFA"/>
  <result pre="relation to the increased risk of accelerated weight gain and" exact="obesity" post="in these categories [ 58]. The Domino trial was"/>
  <result pre="role in a wide range of diseases and also for" exact="metabolic syndrome" post="initiation. Epigenetics investigates heritable modifications to the genome, which"/>
  <result pre="seem to be molecular targets of n-3 LCPUFAs for future" exact="cancer" post="therapy, as emerges from the promising results of in"/>
  <result pre="emerges from the promising results of in vitro studies in" exact="colorectal cancer" post="stem-like cells [ 77] and estrogen receptor-positive breast cancer"/>
  <result pre="from the promising results of in vitro studies in colorectal" exact="cancer" post="stem-like cells [ 77] and estrogen receptor-positive breast cancer"/>
  <result pre="in colorectal cancer stem-like cells [ 77] and estrogen receptor-positive" exact="breast cancer" post="cells [ 78]. In this perspective, n-3 LCPUFAs could"/>
  <result pre="colorectal cancer stem-like cells [ 77] and estrogen receptor-positive breast" exact="cancer" post="cells [ 78]. In this perspective, n-3 LCPUFAs could"/>
  <result pre="high-fat content diets (high-fat lard or high-fat fish oil). Maternal" exact="dyslipidemia" post="caused a 4.75-fold increase in fetal liver triacylglycerol accumulation"/>
  <result pre="nutritional intervention in order to prevent the transgenerational risk of" exact="obesity" post="and its complications in children. n-3-LCPUFAs are well known"/>
  <result pre="and could be a key step to the initiation of" exact="metabolic syndrome," post="giving a chance to treat the disease with more"/>
  <result pre="RNAs References References 1. Ogden C.L. Carroll M.D. Prevalence of" exact="obesity" post="and trends in body mass index among US children"/>
  <result pre="April 2019) 7. Valerio G. Licenziati M.R. Health consequences of" exact="obesity" post="in children and adolescents Minerva Pediatr. 2014 66 381"/>
  <result pre="3 14 10.1002/2327-6924.12510 29024553 9. Mottillo S. Filion K.B. The" exact="metabolic syndrome" post="and cardiovascular risk a systematic review and meta-analysis J."/>
  <result pre="Desai M. Jellyman J.K. Epigenomics, gestational programming and risk of" exact="metabolic syndrome" post="Int. J. Obes. 2015 39 633 641 10.1038/ijo.2015.13 25640766"/>
  <result pre="Fish and seafood consumption during pregnancy and the risk of" exact="asthma" post="and allergic rhinitis in childhood: A pooled analysis of"/>
  <result pre="seafood consumption during pregnancy and the risk of asthma and" exact="allergic rhinitis" post="in childhood: A pooled analysis of 18 European and"/>
  <result pre="consumption during pregnancy and the risk of asthma and allergic" exact="rhinitis" post="in childhood: A pooled analysis of 18 European and"/>
  <result pre="from fish or fish-oil supplements, but not alpha-linolenic acid, benefit" exact="cardiovascular disease" post="outcomes in primary- and secondary-prevention studies: A systematic review"/>
  <result pre="480 10.1111/j.1464-5491.2006.01858.x 16681555 23. May A.L. Kuklina E.V. Prevalence of" exact="cardiovascular disease" post="risk factors among US adolescents Pediatrics 2012 129 1035"/>
  <result pre="1035 1041 10.1542/peds.2011-1082 22614778 24. Zimmet P. Alberti K.G. The" exact="metabolic syndrome" post="in children and adolescents - an IDF consensus report"/>
  <result pre="306 10.1111/j.1399-5448.2007.00271.x 17850473 25. Huang P.L. A comprehensive definition for" exact="metabolic syndrome" post="Dis. Model Mech. 2009 2 231 237 10.1242/dmm.001180 19407331"/>
  <result pre="26. Grundy S.M. Cleeman J.I. Diagnosis and management of the" exact="metabolic syndrome" post="Exec. Summ. Cardiol. Rev. 2005 13 322 327 27."/>
  <result pre="29. Lopez-Huertas E. The effect of EPA and DHA on" exact="metabolic syndrome" post="patients: A systematic review of randomised controlled trials Br."/>
  <result pre="657 665 10.1111/obr.12189 44. Burrows T. Collins C.E. Omega-3 index," exact="obesity" post="and insulin resistance in children Int. J. Pediatr. Obes."/>
  <result pre="on body weight and insulin resistance in pubertal children with" exact="obesity" post="Pediatr. Obes. 2018 14 e12499 10.1111/ijpo.12499 30590877 46. Svensson"/>
  <result pre="effectiveness of ω-3 polyunsaturated fatty acid interventions during pregnancy on" exact="obesity" post="measures in the offspring: An up-to-date systematic review and"/>
  <result pre="acid DHA modulates p53, survivin, and microRNA-16-1 expression in KRAS-mutant" exact="colorectal cancer" post="stem-like cells Genes Nutr. 2018 13 8 10.1186/s12263-018-0596-4 29619114"/>
  <result pre="DHA modulates p53, survivin, and microRNA-16-1 expression in KRAS-mutant colorectal" exact="cancer" post="stem-like cells Genes Nutr. 2018 13 8 10.1186/s12263-018-0596-4 29619114"/>
  <result pre="R.A. Choi M.S. MicroRNAs in the regulation of adipogenesis and" exact="obesity" post="Curr. Mol. Med. 2011 11 304 316 10.2174/156652411795677990 21506921"/>
  <result pre="D.E. Castro R. Epigenetic modifications: Basic mechanisms and role in" exact="cardiovascular disease" post="Circulation 2011 123 2145 2156 10.1161/CIRCULATIONAHA.110.956839 21576679 83. Ramaiyan"/>
  <result pre="27822319 95. Herrera B.M. Keildson S. Genetics and epigenetics of" exact="obesity" post="Maturitas 2011 69 41 49 10.1016/j.maturitas.2011.02.018 21466928 ijms-20-02118-t001_Table 1"/>
  <result pre="in adipocyte differentiation stimulator increase miRNA-143 regulation of adipogenesis and" exact="obesity" post="Vascular inflammation miRNA-21, miRNA-125a, mi-RNA146a, miR-146b, miRNA-155 targets of"/>
 </snippets>
</snippetsTree>
